Want to join the conversation?
Biopharmaceutical company $NKTR said it has commenced dosing in the Phase 1/2 clinical study of the usage of NKTR-214 in the treatment of solid tumors. NKTR-214 is an immuno-oncology candidate that is designed to activate and multiply the patient's own tumor-killing T cells in order to fight cancer more effectively.
$GOOG’s Waymo accuses Uber of stealing its intellectual property. Startup Otto, which was recently acquired by Uber, also named in the lawsuit. Stage set for another dramatic legal battle!
We all knew $VALE CEO Murilo Ferreira was going out soon, but now I hear he has no idea who will succeed him!
$JCP, another traditional retailer that just shocked us with its biggest number of store closures.